Author: admin

NJ YZ  is participating in the China's Top Domestic & Multinational Clinical Development Leaders Summit in Shanghai from 8th Nov. to 10th Nov. 2017. We will present more information later about this big event in China! For the event website, please check :http://www.chinatrialsevent.com/...

The real-world study conference was held from 29th June to 30th June in Shanghai 2017. In this meeting, Dr.Yuri Zaretsky presented a speech named RWE PHARMACOVIGILANCE: GLOBAL AND LOCAL OUTLOOK. In this speech, Dr. Yuri showed his ideas about PV in real word from global and...

ZM CRO GROUP company President Dr. Yuri Zaretsky has recently started collaborating with Korea Health Industry Development Institute (KHIDI) as an official consultant for Korean pharmaceutical and biotechnology companies - Global Pharma Key Opinion Leader (GPKOL). As GPKOL Dr. Zaretsky is focused on the following issues...

Biological products (BP), or biologics, is a class of heterogeneous medical products derived from different natural source materials (mammalian, insect and plant cell cultures, yeast, etc.) intended to treat, cure, prevent or diagnose diseases and medical conditions [1, 5]. BP introduction...

November, 8-10 2016 managing director of ZM CRO GROUP Yuri Zaretsky will moderate series of sections and conduct a workshop for participants of annual Clinical Trials in Russia Forum (Russia, Moscow) organized by «Adam Smith Conferences» company. The sections will focus on data management and early access...

NJ YZ Clinical Trials and Consulting team is attending a networking event “China Bio Partnering Forum” held in Suzhou, China on May 18- 19, 2016....